Key results: 12 mg dose: Average weight loss of 24.2 percent of body weight 8 mg dose: Average weight loss of 22.8 percent 4 mg dose: Average weight loss of 17.0 percent Over 90 percent of participants at 8 or 12 mg lost at least 10 percent of body weight Over 75 percent at 12 mg lost at least 20 percent Crucially, the weight loss curve had not yet plateaued at 48 weeks, suggesting longer treatment may produce even greater results
8 When food is digested, it is broken down into its simplest forms
Tirzepatide was administered at a dose assumed to be below the lowest clinically applicable dose of 5 mg, based on C max [46], and the same dose was used for retatrutide
Our study demonstrated that GLP-1 analogs reduced lean mass in MC4R KO mice, which is in line with previous reports indicating that GLP-1 treatment can cause muscle loss [37]
Link Karacabeyli D, Lacaille D
2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user
